Live monovalent influenza H2N2 vaccine (PATH)

N/A

Report date: 2022/12/31 19:25:32

Base Information

Drug NameLive monovalent influenza H2N2 vaccine (PATH)
Drug Alias Name活单价流感H2N2疫苗-PATHLAIV H2N2 vaccineMonovalent A/17/California/66/395 (LAIV H2N2) vaccineLAIV H2N2
ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Univalent vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPath
China Registration ClassN/A

Develop Information

Active CompaniesPath
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A